Loading…
Loading…
research
PaxMedica (OTCQB: PXMD) is a forward-thinking clinical-stage biopharmaceutical company, unwavering in its dedication to advancing innovative therapies for individuals and families impacted by neurodevelopmental disorders. With a primary focus on Autism Spectrum Disorder (ASD), PaxMedica is committed to developing groundbreaking treatments that address the unmet medical needs of those affected by this complex condition. Our team of dedicated experts and scientists collaborates passionately to bring meaningful advancements to the field, aiming to provide relief from the core symptoms of autism and improve the overall quality of life for those affected. We believe in the power of scientific innovation, and we are committed to making a real difference for individuals with ASD and their families. Join us on our mission to bring about transformative change in the world of neurodevelopmental disorders.
PaxMedica (OTCQB: PXMD) is a forward-thinking clinical-stage biopharmaceutical company, unwavering in its dedication to advancing innovative therapies for individuals and families impacted by neurodevelopmental disorders. With a primary focus on Autism Spectrum Disorder (ASD), PaxMedica is committed to developing groundbreaking treatments that address the unmet medical needs of those affected by this complex condition. Our team of dedicated experts and scientists collaborates passionately to bring meaningful advancements to the field, aiming to provide relief from the core symptoms of autism and improve the overall quality of life for those affected. We believe in the power of scientific innovation, and we are committed to making a real difference for individuals with ASD and their families. Join us on our mission to bring about transformative change in the world of neurodevelopmental disorders.
PaxMedica Inc. has been mentioned across 1 podcast.
Represent this company? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
